Article
The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population.
Thrombosis and haemostasis - 1 Sept 1998
Souto J C, Coll I, Llobet D, del Río E, Oliver A, Mateo J, Borrell M, Fontcuberta J
Abstract excerpt
We investigated the prevalence of the new recently reported mutation in the prothrombin gene (20210 A) in a sample of 116 unrelated patients with venous thromboembolism. We found 20 heterozygous carriers (17.2%, CI 95% 10.4-21.1). In comparison, we observed 13 carriers among 201 healthy unmatched controls (6.5%, CI 3.5-10.8). The 20210 A mutation seems to increase the risk of venous thrombosis 3-fold (odds ratio...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
